良性前列腺增生的激光微创治疗进展

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (808 KB)
输出: BibTeX | EndNote (RIS)

摘要良性前列腺增生的微创治疗随着科技的发展,各种激光治疗系统等新的治疗手段逐渐应用于临床,这些治疗方法不仅能有效地改善由良性前列腺增生引起的下尿路症状,同时展现出越来越多在减少术中术后并发症方面的优势,大有取代TURP这个治疗金标准的趋势。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	王翔
	邓耀良

关键词 ：良性前列腺增生, 激光, 微创

Abstract：With the development of science and technology, various new treatments such as laser treatment system, the minimally invasive treatment of benign prostatic hyperplasia, are gradually applied in clinical practice. The treatment can effectively improve the urinary tract symptoms, and show a more and more advantages in reducing intraoperative complications, which may replace TURP as the gold standard treatment.

Key words： benign prostatic hyperplasia laser minimal invasion

收稿日期: 2014-06-20

ZTFLH:

R697

通讯作者: 邓耀良,dylkf317@163.com

引用本文:

王翔,邓耀良. 良性前列腺增生的激光微创治疗进展[J]. 微创泌尿外科杂志, 2014, 3(4): 250-254.
Wang Xiang,Deng Yaoliang. Advances in the laser minimally invasive treatment of benign prostatic hyperplasia. JOURNAL OF MINIMALLY INVASIVE UROLOGY, 2014, 3(4): 250-254.

链接本文:

http://journal20.magtechjournal.com/Jwk_zgmnwk/CN/abstract/abstract893.shtml 或 http://journal20.magtechjournal.com/Jwk_zgmnwk/CN/Y2014/V3/I4/250

[1]Lee C, Kozlowski JM, Grayhack JT. Intrinsic and extrinsic factors controlling benign prostatic growth. Prostate, 1997,31(2): 131-138.
[2]Platz EA, Smit E, Curhan GC, et al. Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. Urology, 2002,59(6): 877-883.
[3]Saigal CS, Joyce G. Economic costs of benign prostatic hyperplasia in the private sector. J Urol, 2005,173(4): 1309-1313.
[4]Tasci AI, Ilbey YO, Tugcu V, et al. Transurethral resection of the prostate with monopolar resectoscope: single-surgeon experience and long-term results after 3589 procedures. Urology, 2011,78(5): 1151-1155.
[5]Costello AJ. Laser prostatectomy. Med J Aust, 1992,157(7): 504.
[6]Anson K, Nawrocki J, Buckley J, et al. A multicenter, randomized, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology, 1995,46(3): 305-310.
[7]Cowles RR, Kabalin JN, Childs S, et al. A prospective randomized comparison of transurethral resection to visual laser ablation of the prostate for the treatment of benign prostatic hyperplasia. Urology, 1995,46(2): 155-160.
[8]Keoghane SR, Lawrence KC, Gray AM, et al. A double-blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: a 3-year follow-up. BJU Int, 2000,85(1): 74-78.
[9]Gilling PJ, Cass CB, Cresswell MD, et al. Holmium laser resection of the prostate: preliminary results of a new method for the treatment of benign prostatic hyperplasia. Urology, 1996,47(1): 48-51.
[10]Krambeck AE, Handa SE, Lingeman JE. Experience with more than 1,000 holmium laser prostate enucleations for benign prostatic hyperplasia. J Urol, 2010,183(3): 1105-1109.
[11]Gilling PJ, Mackey M, Cresswell M, et al. Holmium laser versus transurethral resection of the prostate: a randomized prospective trial with 1-year followup. J Urol, 1999,162(5): 1640-1644.
[12]Gilling PJ, Wilson LC, King CJ, et al. Long-term results of a randomized trial comparing holmium laser enucleation of the prostate and transurethral resection of the prostate: results at 7 years. BJU Int, 2012,109(3): 408-411.
[13]Tan A, Liao C, Mo Z, et al. Meta-analysis of holmium laser enucleation versus transurethral resection of the prostate for symptomatic prostatic obstruction. Br J Surg, 2007,94(10): 1201-1208.
[14]Ahyai SA, Chun FK, Lehrich K, et al. Transurethral holmium laser enucleation versus transurethral resection of the prostate and simple open prostatectomy--which procedure is faster?. J Urol, 2012,187(5): 1608-1613.
[15]Kuo RL, Kim SC, Lingeman JE, et al. Holmium laser enucleation of prostate (HoLEP): the Methodist Hospital experience with greater than 75 gram enucleations. J Urol, 2003,170(1): 149-152.
[16]Kuntz RM, Lehrich K, Ahyai SA. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial. Eur Urol, 2008,53(1): 160-166.
[17]Krambeck AE, Handa SE, Lingeman JE. Holmium laser enucleation of the prostate for prostates larger than 175 grams. J Endourol, 2010,24(3): 433-437.
[18]Gerstein NS, Schulman PM, Gerstein WH, et al. Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome. Ann Surg, 2012,255(5): 811-819.
[19]Elzayat E, Habib E, Elhilali M. Holmium laser enucleation of the prostate in patients on anticoagulant therapy or with bleeding disorders. J Urol, 2006,175(4): 1428-1432.
[20]Shah HN, Mahajan AP, Sodha HS, et al. Prospective evaluation of the learning curve for holmium laser enucleation of the prostate. J Urol, 2007,177(4): 1468-1474.
[21]Elzayat EA, Elhilali MM. Holmium laser enucleation of the prostate (HoLEP): long-term results, reoperation rate, and possible impact of the learning curve. Eur Urol, 2007,52(5): 1465-1471.
[22]Jeon SH, Han KS, Yoo KH, et al. How many cases are necessary to develop competence for laparoscopic radical nephrectomy?. J Endourol, 2009,23(12): 1965-1969.
[23]Kaul S, Shah NL, Menon M. Learning curve using robotic surgery. Curr Urol Rep,2006,7(2): 125-129.
[24]Capitan C, Blazquez C, Martin MD, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up. Eur Urol, 2011,60(4): 734-739.
[25]Whelan JP, Bowen JM, Burke N, et al. A prospective trial of GreenLight PVP (HPS120) versus transurethral resection of the prostate in the treatment of lower urinary tract symptoms in Ontario, Canada. Can Urol Assoc J, 2013,7(9-10): 335-341.
[26]Chung DE, Wysock JS, Lee RK, et al. Outcomes and complications after 532 nm laser prostatectomy in anticoagulated patients with benign prostatic hyperplasia. J Urol, 2011,186(3): 977-981.
[27]Ruszat R, Wyler S, Forster T, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol, 2007,51(4): 1031-1041.
[28]Rajbabu K, Chandrasekara SK, Barber NJ, et al. Photoselective vaporization of the prostate with the potassium-titanyl-phosphate laser in men with prostates of >100 mL. BJU Int, 2007,100(3): 593-598.
[29]Tugcu V, Tasci AI, Sahin S, et al. Outcomes of 80 W KTP laser vaporization of the large prostate. Urol Int, 2007,79(4): 316-320.
[30]Nunez R, Hurd KJ, Noble BN, et al. Incidental prostate cancer revisited: early outcomes after holmium laser enucleation of the prostate. Int J Urol, 2011,18(7): 543-547.
[31]Bach T, Netsch C, Haecker A, et al. Thulium:YAG laser enucleation (VapoEnucleation) of the prostate: safety and durability during intermediate-term follow-up. World J Urol, 2010,28(1): 39-43.
[32]Netsch C, Bach T, Herrmann TR, et al. Thulium:YAG VapoEnucleation of the prostate in large glands: a prospective comparison using 70- and 120-W 2-microm lasers. Asian J Androl, 2012,14(2): 325-329.
[33]Netsch C, Bach T, Pohlmann L, et al. Comparison of 120-200 W 2 mum thulium:yttrium-aluminum-garnet vapoenucleation of the prostate. J Endourol, 2012,26(3): 224-229.
[34]Xia S J, Zhuo J, Sun XW, et al. Thulium laser versus standard transurethral resection of the prostate: a randomized prospective trial. Eur Urol, 2008,53(2): 382-389.
[35]Zhuo J, Wei HB, Zhao FJ, et al. Two-micrometer thulium laser resection of the prostate-tangerine technique for patients with acute urinary retention. Lasers Med Sci, 2013.
[36]Netsch C, Bach T, Herrmann TR, et al. Evaluation of the learning curve for Thulium VapoEnucleation of the prostate (ThuVEP) using a mentor-based approach. World J Urol, 2013,31(5): 1231-1238.
[37]Netsch C, Stoehrer M, Bruning M, et al. Safety and effectiveness of Thulium VapoEnucleation of the prostate (ThuVEP) in patients on anticoagulant therapy. World J Urol, 2014,32(1): 165-172.
[38]Seitz M, Sroka R, Gratzke C, et al. The diode laser: a novel side-firing approach for laser vaporisation of the human prostate--immediate efficacy and 1-year follow-up. Eur Urol, 2007,52(6): 1717-1722.
[39]Buisan O, Saladie JM, Ruiz JM, et al. [Diode laser enucleation of the prostate (Dilep): technique and initial results]. Actas Urol Esp, 2011,35(1): 37-41.
[40]Van Rij S, Gilling PJ. In 2013, holmium laser enucleation of the prostate (HoLEP) may be the new 'gold standard'. Curr Urol Rep, 2012,13(6): 427-432.